Evofem BiosciencesEVFM -3.86% Days Inventory is 335.96 as of Mar. 2026, which is 9% below its 10-year median of 368.94. The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, Evofem Biosciences ranks better than 61.44% on this metric.
The historical rank and industry rank for Evofem Biosciences's Days Inventory or its related term are showing as below:
EVFM'
s Days Inventory Range Over the Past 10 Years
Min: 106.96 Med: 368.94 Max: 5585.75
Current: 138.92
During the past 13 years, Evofem Biosciences's highest Days Inventory was 5585.75. The lowest was 106.96. And the median was 368.94.
EVFM's Days Inventory is ranked better than 61.44% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs EVFM: 138.92
Evofem Biosciences's Days Inventory
declined
from Mar. 2025 (480.00) to Mar. 2026 (335.96).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Evofem Biosciences's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Evofem Biosciences's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.68.
Evofem Biosciences (OTCPK:EVFM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Evofem Biosciences's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Evofem Biosciences's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Evofem Biosciences Days Inventory Related Terms
Evofem Biosciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Evofem Biosciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVFM vs LYRA, CLSDQ, ATXI: Days Inventory Comparison
For the Biotechnology subindustry, Evofem Biosciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evofem Biosciences Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Evofem Biosciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Evofem Biosciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evofem Biosciences (EVFM) has a Days Inventory of 335.96 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Evofem Biosciences and its competitors. This is near median its historical median of 368.94. Over the past decade, Evofem Biosciences' Days Inventory has ranged from 106.96 to 5,585.75. According to the industry distribution chart, Evofem Biosciences ranks #246 out of 638 companies in the Biotechnology industry, placing it in the top 38.6%.
Is Evofem Biosciences' Days Inventory too high?
Evofem Biosciences' current Days Inventory of 335.96 is near median its 10-year median of 368.94. Over the past 10 years, this metric has ranged from a low of 106.96 to a high of 5,585.75. The Biotechnology industry median Days Inventory is 183.88. Evofem Biosciences' value of 335.96 is 82.7% above this industry median. Based on the distribution chart, Evofem Biosciences ranks #246 out of 638 companies in the Biotechnology industry, which is above the industry midpoint.
How does Evofem Biosciences' Days Inventory compare to LYRA and CLSDQ?
According to the Biotechnology industry distribution chart, Evofem Biosciences ranks #246 out of 638 companies for Days Inventory. This puts Evofem Biosciences in the upper half of its industry. The industry median Days Inventory is 183.88. Evofem Biosciences' value of 335.96 is 82.7% above this benchmark. Historically, Evofem Biosciences' own Days Inventory has ranged from 106.96 to 5,585.75 over the past decade. While the company's 10-year median is 368.94 vs. the industry median of 183.88, Evofem Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evofem Biosciences's current Days Inventory of 335.96 is 82.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Evofem Biosciences and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evofem Biosciences's current Days Inventory is 335.96, which is near median its own 10-year median of 368.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evofem Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Evofem Biosciences (EVFM) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 20.3% below its estimated fair value. The current Days Inventory is 335.96, which is near median its 10-year median of 368.94 and 82.7% above the Biotechnology industry median of 183.88. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Evofem Biosciences (EVFM), the current Days Inventory is 335.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. The company's product, Phexxi (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVFM has been successfully added to your 